Mediastinal gray zone lymphoma

Haematologica

Volumn 96, Issue 4, 2011, Pages 496-499

  Quintanilla Martinez, Leticia ^a   Fend, Falko ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN EXPRESSION; B CELL LYMPHOMA; CANCER CLASSIFICATION; CANCER MORPHOLOGY; CARCINOGENESIS; EDITORIAL; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; MEDIASTINAL GRAY ZONE LYMPHOMA; MEDIASTINUM MASS; NODULAR SCLEROSIS HODGKIN LYMPHOMA; PROGNOSIS; SIGNAL TRANSDUCTION;

HUMANS; LYMPHOMA; MEDIASTINAL NEOPLASMS;

EID: 79953852748     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2011.043026     Document Type: Editorial

References (19)

1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al., eds. WHO Classification of Tumour of Haematopoietic and Lymphoid Tissues. Lyon, 2008.
2. Jaffe ES, Stein H, Swerdlow SH, Campo E, Pileri S, Harris NL. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin Lymphoma. In: IARC, ed. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, 2008:267-268.
3. Möller P, Moldenhauer G, Momburg F, Lämmler B, Eberlein-Gonska M, Kiesel S, Dörken B. Mediastinal lymphoma of clear cell type is a tumor corresponding to terminal steps of B cell differentiation. Blood. 1987;69(4):1087-1095.
4. Pileri SA, Gaidano G, Zinzani PL, Falini B, Gaulard P, Zucca E, et al. Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins. Am J Pathol. 2003;162(1):243-253.
5. Calaminici M, Piper K, Lee AM, Norton AJ. CD23 expression in medi-astinal large B-cell lymphomas. Histopathology. 2004;45(6):619-624.
6. Copie-Bergman C, Plonquet A, Alonso MA, Boulland ML, Marquet J, Divine M, et al. MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas. Mod Pathol. 2002;15(11):1172-1180.
7. Rodig SJ, Savage KJ, LaCasce AS, Weng A P, Harris NL, Shipp MA, et al. Expression of TRAF1 and nuclear c-Rel distinguishes primary mediasti-nal large cell lymphoma from other types of diffuse large B-cell lym-phoma. Am J Surg Pathol. 2007;31(1):106-112.
8. Joos S, Otaño-Joos MI, Ziegler S, Brüderlein S, du Manoir S, Bentz M, et al. Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood 1996;87(4):1571-1578.
9. Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne RD, et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med. 2003;198(6):851-862.
10. Savage KJ, Monti S, Kutok JL, Cattoretti G, Neuberg D, De Leval L, et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood. 2003;102(12): 3871-3879.
11. Joos S, Küpper M, Ohl S, von Bonin F, Mechtersheimer G, Bentz M, et al. Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells. Cancer Res. 2000;60(3):549-552.
12. Rüdiger T, Jaffe ES, Delsol G, deWolf-Peeters C, Gascoyne RD, Georgii A, et al. Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma). Ann Oncol. 1998;9 (Suppl 5):S31-S38.
13. Traverse-Glehen A, Pittaluga S, Gaulard P, Sorbara L, Alonso MA, Raffeld M, Jaffe ES. Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma. Am J Surg Pathol. 2005;29(11):1411-1421.
14. Quintanilla-Martinez L, de Jong D, de Mascarel A, Hsi ED, Kluin P, Natkunam Y, et al. Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France. J Hematop. 2009;2(4):211-236.
15. Eberle FC, Rodriguez-Canales J, Wei L, Hanson JC, Killian JK, Sun H-W, et al. Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lym-phoma. Haematologica 2011;96(4):558-566.
16. Ehlers A, Oker E, Bentink S, Lenze D, Stein H, Hummel M. Histone acetylation and DNA demethylation of B cells result in a Hodgkin-like phenotype. Leukemia. 2008;22(4):835-841.
17. Ushmorov A, Ritz O, Hummel M, Leithäuser F, Möller P, Stein H, Wirth T. Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression. Blood. 2004;104(10):3326-3334.
18. von Wasielewski R, Mengel M, Fischer R, Hansmann ML, Hübner K, Franklin J, et al. Classical Hodgkin's disease. Clinical impact of the immunophenotype. Am J Pathol. 1997;151(4):1123-1130.
19. Portlock CS, Donnelly GB, Qin J, Straus D, Yahalom J, Zelenetz A, et al. Adverse prognostic significance of CD20 positive Reed-Sternberg cells in classical Hodgkin's disease. Br J Haematol. 2004;125(6):701-708.